These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7146090)

  • 1. The biochemical discrimination of subtypes of depressive disorders: an outline of our studies on norepinephrine metabolism and psychoactive drugs in the endogenous depressions since 1967.
    Schildkraut JJ
    Pharmacopsychiatria; 1982 Jul; 15(4):121-7. PubMed ID: 7146090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
    Schatzberg AF; Orsulak PJ; Rosenbaum AH; Kruger ER; Schildkraut JJ; Cole JO
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):35-9. PubMed ID: 7440524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High positive correlation between urinary free tyramine excretion rate and "whole body" norepinephrine turnover in depressed patients.
    Linnoila M; Karoum F; Potter WZ
    Biol Psychiatry; 1982 Sep; 17(9):1031-6. PubMed ID: 7138992
    [No Abstract]   [Full Text] [Related]  

  • 4. Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions.
    Schatzberg AF; Orsulak PJ; Rosenbaum AH; Maruta T; Kruger ER; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1982 Apr; 139(4):471-5. PubMed ID: 7065292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1989 Feb; 31(786):13-20. PubMed ID: 2563894
    [No Abstract]   [Full Text] [Related]  

  • 6. Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders.
    Schatzberg AF; Samson JA; Bloomingdale KL; Orsulak PJ; Gerson B; Kizuka PP; Cole JO; Schildkraut JJ
    Arch Gen Psychiatry; 1989 Mar; 46(3):260-8. PubMed ID: 2783211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affective disorders: biological aspects.
    Ban TA
    Acta Neurol (Napoli); 1985 Apr; 7(2):129-34. PubMed ID: 2409751
    [No Abstract]   [Full Text] [Related]  

  • 8. New psychoactive drugs.
    Murray JB
    Genet Soc Gen Psychol Monogr; 1985 Nov; 111(4):429-53. PubMed ID: 2873081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of norepinephrine in affective disorders (author's transl)].
    Puech AJ; Lecrubier Y; Simon P
    Encephale; 1979; 5(5 Suppl):507-19. PubMed ID: 548273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Norepinephrine metabolism in subtypes of depressive disorders.
    Schildkraut JJ
    Psychopharmacol Bull; 1974 Oct; 10(4):49-50. PubMed ID: 4431872
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-mortem evidence from human brain tissue of disturbed glucose metabolism in mood and psychotic disorders.
    Regenold WT; Phatak P; Kling MA; Hauser P
    Mol Psychiatry; 2004 Aug; 9(8):731-3. PubMed ID: 15098005
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPG.
    Blombery PA; Kopin IJ; Gordon EK; Markey SP; Ebert MH
    Arch Gen Psychiatry; 1980 Oct; 37(10):1095-8. PubMed ID: 7425794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of personality factors on the success of psychopharmacotherapy].
    Rüger U
    Psychiatr Prax; 1985 Jan; 12(1):5-7. PubMed ID: 2858900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of biological psychiatric depression research (author's transl)].
    Matussek N
    MMW Munch Med Wochenschr; 1981 May; 123(19):793-4. PubMed ID: 6262640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic treatment of depressive subtypes.
    Brotman AW; Falk WE; Gelenberg AJ
    Psychiatr Med; 1988; 6(3):92-113. PubMed ID: 3062675
    [No Abstract]   [Full Text] [Related]  

  • 16. The Harold E. Himwich Memorial Lecture. Significance of biochemical parameters in the diagnosis, treatment, and prevention of depressive disorders.
    Praag HM
    Biol Psychiatry; 1977 Feb; 12(1):101-31. PubMed ID: 300032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norepinephrine metabolism and psychoactive drugs in the endogenous depressions. 1968.
    Schildkraut JJ; Kopin IJ; Schanberg SM; Durell J
    Pharmacopsychiatry; 1995 Sep; 28 Suppl 1():24-37. PubMed ID: 7480108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolism of noradrenaline and endogenous depression (author's transl)].
    Beckmann H
    Fortschr Neurol Psychiatr Grenzgeb; 1980 Aug; 48(8):415-37. PubMed ID: 6902692
    [No Abstract]   [Full Text] [Related]  

  • 19. Electroconvulsive treatment and lithium carbonate. Their effects on norepinephrine metabolism in patients with primary, major depressions.
    Linnoila M; Karoum F; Rosenthal N; Potter WZ
    Arch Gen Psychiatry; 1983 Jun; 40(6):677-80. PubMed ID: 6221709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic implications of the biochemical features about depressive illness (author's transl)].
    Lôo H
    Encephale; 1981; 7(4 Suppl):429-40. PubMed ID: 6172268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.